Lyser D Tablet is a combination of two medicines: Diclofenac and Serratiopeptidase. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) which works by blocking the release of certain chemical messengers in the brain that cause pain, fever and inflammation (redness and swelling). Serratiopeptidase is an enzyme which works by breaking down abnormal proteins at the site of inflammation, and promotes healing.
Taking diclofenac with alcohol can increase your risk of stomach bleeding.
WEIGH RISKS VS BENEFITS
Lyser D Tablet is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
No information is available on the use of Lyser D Tablet during lactation. Please consult your doctor.
Do not drive unless you are feeling well. Lyser D Tablet may cause headaches, blurred vision, dizziness or drowsiness in some patients. This may affect your ability to drive.
Lyser D Tablet should be used with caution in patients with kidney disease. Dose adjustment of Lyser D Tablet may be needed. Please consult your doctor.
Lyser D Tablet should be used with caution in patients with liver disease. Dose adjustment of Lyser D Tablet may be needed. Please consult your doctor. Regular monitoring of liver function tests is recommended in patients with liver disease if this medicine is to be taken for a long time.
What were the side-effects while using Lyser D Tablet?
No Side Effect
How do you take Lyser D Tablet?
With or without food
How much was the improvement?
Please rate Lyser D Tablet on price
What are you using Lyser D Tablet for?
Survey Participants: 60
“The following are the results of on-going survey on 1mg.com for Lyser D Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 1st Dec 2017.